Home600196 • SHA
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs A
Previous close
¥27.29
Day range
¥26.24 - ¥27.28
Year range
¥20.38 - ¥30.44
Market cap
62.72B CNY
Avg Volume
21.64M
P/E ratio
33.29
Dividend yield
1.03%
Primary exchange
SHA
In the news
Financials
Income Statement
Revenue
Net income
(CNY) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 10.45B | 12.30% |
Operating expense | 4.11B | -4.30% |
Net income | 785.84M | 55.43% |
Net profit margin | 7.52 | 38.49% |
Earnings per share | — | — |
EBITDA | 1.60B | 229.39% |
Effective tax rate | 15.05% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 15.63B | -1.12% |
Total assets | 115.26B | 4.06% |
Total liabilities | 56.07B | 2.35% |
Total equity | 59.19B | — |
Shares outstanding | 2.66B | — |
Price to book | 1.53 | — |
Return on assets | 2.03% | — |
Return on capital | 2.49% | — |
Cash Flow
Net change in cash
(CNY) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 785.84M | 55.43% |
Cash from operations | 1.08B | 65.68% |
Cash from investing | 210.24M | 122.80% |
Cash from financing | -1.59B | 11.34% |
Net change in cash | -389.75M | 80.29% |
Free cash flow | -2.97B | 27.05% |
About
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Founded
1994
Website
Employees
39,309